New Real-World Evidence Study Demonstrates Vibrant System’s Continuous Effectiveness and Exceptional Tolerability for Chronic Idiopathic ConstipationAustin, TX, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Vibrant Gastro announced today the publication of new real-world evidence in Clinical and Translational Gastroenterology demonstrating the long-term effectiveness and safety of the Vibrant System™, a U.S. FDA-cleared, drug-free treatment for adults with chronic idiopathic constipation (CIC).
Vibrant Gastro Announces Federal Supply Schedule Contract Approval, Expanding Access to Veterans and Federal Health PatientsAustin, TX, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Vibrant Gastro, inventor of the Vibrant® System, today announced that its FDA‑cleared, drug‑free treatment for chronic idiopathic constipation (CIC) is now available on the General Services Administration’s (GSA) Federal Supply Schedule (FSS) contract. This milestone expands access to care for millions of Americans served by the U.S. Department of Veterans Affairs (VA), Department of Defense, TRICARE, Indian Health Service, and other federal and state entities.
Trio of Prestigious Awards Honors Drug-Free Chronic Constipation Treatment: Vibrant®Awards follow studies demonstrating Vibrant’s safety, affordability and effectiveness
